Aclarion, Inc. (NASDAQ:ACONW) Sees Large Decrease in Short Interest

Aclarion, Inc. (NASDAQ:ACONW) saw a large decline in short interest during the month of July. As of July 15th, there was short interest totaling 2,622 shares, a decline of 42.8% from the June 30th total of 4,580 shares. Based on an average trading volume of 5,099 shares, the short-interest ratio is currently 0.5 days.

Aclarion Stock Performance

ACONW stock traded up $0.00 during midday trading on Wednesday, hitting $0.02. The company’s stock had a trading volume of 202 shares, compared to its average volume of 20,923. The firm’s 50-day moving average is $0.03 and its 200-day moving average is $0.03. Aclarion has a 12 month low of $0.02 and a 12 month high of $0.23.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.